Immunologic Research

Papers
(The H4-Index of Immunologic Research is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia76
Somatic hypermutation defects in two adult hyper immunoglobulin M patients69
Belimumab 10 years later: how drug positioning has changed67
A case of atypical infantile de novo antiphospholipid syndrome presenting with neonatal ischemic stroke without any triggering risk factors as a “second hit” and review of the literature65
Rapid generation of an RBL cellular model to study proteins that cause allergenic reactions in vitro53
Mitochondrial sirtuins 3, 4 and 5 in patients with psoriasis52
PS77: a novel peptide with α-helical structure for targeted anti-inflammatory therapy in biomaterials design45
Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey40
Quantitative evaluation of citrullinated fibrinogen for detection of neutrophil extracellular traps39
Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis32
Rubella-associated granuloma in a patient with a compound heterozygous RAG1 defect and review of the literature29
RNA-based cancer vaccines: mechanisms, clinical progress, and translational challenges29
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis28
MiR-29a-3p negatively regulates circulating Tfh memory cells in patients with Graves’ disease by targeting ICOS27
Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance25
The cGAS-STING axis: a comprehensive review from immune defense to disease pathogenesis25
ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis22
Clinical relevance and frequency of cytoplasmic patterns observed in ANA-Hep-2: experience of Cairo University Hospitals22
Immunomodulatory activities of carbon quantum dots on the primary macrophages and whole splenocytes20
A ubiquitin–proteasome system-related signature to predict prognosis, immune infiltration, and therapy efficacy for breast cancer19
Lipocalin 2—not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials19
0.2641270160675